CME — CME Group Inc.
NASDAQ
Q1 2026 Earnings Call Summary
April 22, 2026
CME Group Q1 2026 Earnings Call Summary
1. Key Financial Results and Metrics
- Record Revenue: CME Group reported record revenue of $1.9 billion, up 14% year-over-year, with a $238 million increase from Q1 2025.
- Average Daily Volume (ADV): Achieved a record ADV of 36.2 million contracts, a 22% increase year-over-year.
- Clearing and Transaction Fees: Grew by 15% year-over-year, contributing $205 million to revenue.
- Adjusted Operating Income: Reached $1.4 billion, with a historic adjusted operating margin of 72.8%.
- Adjusted Net Income: Set a record at $1.2 billion, or $3.36 per share, a 20% increase from Q1 2025.
- Shareholder Returns: Returned $3.2 billion to shareholders, including $2.7 billion in dividends and $536 million in share repurchases.
2. Strategic Updates and Business Highlights
- Record Volume Across Asset Classes: For the first time, CME achieved record volume across all six asset classes: rates, equities, energy, agricultural products, metals, and foreign exchange.
- International Growth: International ADV reached a record 11.4 million contracts, a 30% increase from 2025.
- Innovation Initiatives:
- Approved cross-margining agreements for end-user clients.
- Launching 24/7 crypto trading on May 29, 2026.
- Filing to change Micro Equity Index options to financially settled contracts.
- New Facility: The Dallas facility is on track to open in summer 2026, aimed at enhancing client testing capabilities.
3. Forward Guidance and Outlook
- CME Group expressed confidence in continuing to deliver value to clients and shareholders throughout 2026, supported by strong performance and ongoing investments in technology and product innovation.
4. Bad News, Challenges, or Points of Concern
- RPC Decline: Average rate per contract (RPC) decreased due to increased trading volume and a shift towards lower-priced contracts, particularly in the energy sector.
- Market Volatility: Concerns were raised about the nature of current market volatility, which could impact customer behavior and the overall health of the underlying customer base.
- Regulatory Risks: The potential for regulatory changes affecting new product offerings, such as financial KPI contracts, remains a concern.
5. Notable Q&A Insights
- Cross-Margining Impact: The new cross-margining program could save clients up to 80% on margin requirements, with significant interest from clearing members.
- Prediction Markets Growth: Over 150,000 new accounts have traded CME's prediction markets, with a notable shift towards market-based contracts.
- BrokerTec Chicago: Early adoption is promising, with a 93% month-over-month increase in ADV in March, indicating strong client interest in the platform.
- Stablecoin and Tokenization: CME is progressing on its stablecoin initiative and cash tokenization project, with plans to go live by year-end 2026.
This summary encapsulates CME Group's robust performance in Q1 2026 while highlighting strategic initiatives and potential challenges ahead.
